手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 頭痛影響テスト-6 (HIT-6)× | EORTC QLQ-C30× | |
|---|---|---|
| 分野 | 健康アウトカム | 健康アウトカム |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2003 | 1993 |
| 提唱者≠ | Mark Kosinski et al. | Nico Aaronson et al. |
| 種類≠ | Self-report functional impact questionnaire | Self-report quality of life questionnaire |
| 原典≠ | Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974. DOI ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 別名 | HIT-6, Headache Impact Test, HIT | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 関連≠ | 4 | 5 |
| 概要≠ | The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGateデータセット ↗ |
|
|